SKI Market

A+| A| A-|

Indian Indices

Sensex

77,094.07 291.17
( 0.38%)

Global Indices

Nasdaq

51,748.06 162.36
(0.31%)

Dow Jones

7,496.17 -25.41
(-0.34%)

Hang Seng

72,454.13 1,204.07
(1.69%)

Nikkei 225

10,441.93 78.66
(0.76%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7814421

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

33.47

107760.82

EPS(TTM)

Face Value()

Div & Yield %

38.57

0.62

Back

Rallis India standalone net profit declines 81.82% in the December 2025 quarter

Jan 21,2026

Net profit of Rallis India declined 81.82% to Rs 2.00 crore in the quarter ended December 2025 as against Rs 11.00 crore during the previous quarter ended December 2024. Sales rose 19.35% to Rs 623.00 crore in the quarter ended December 2025 as against Rs 522.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	623.00	522.00	19
OPM %	9.31	8.43	-
PBDT	65.00	48.00	35
PBT	36.00	19.00	89
NP	2.00	11.00	-82

77,094.07 291.17 ( 0.38%)

51,748.06 162.36 (0.31%)

7,496.17 -25.41 (-0.34%)

72,454.13 1,204.07 (1.69%)

10,441.93 78.66 (0.76%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)